May 6, 2020
Nanobiotix’s Phase 1 trial in pancreatic cancer safe to proceed (FDA)
another step forward for NBTXR3 activated by radiation therapy
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Pancreatic cancer
March 27, 2017
Erytech Pharma reports positive results from pancreatic cancer study
Erytech Pharma, a French clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, has reported positive topline results from its Phase 2b clinical study evaluating its product candidate, eryaspase (GRASPA), in combination with chemotherapy for the treatment of second-line metastatic pancreatic cancer.
January 16, 2017
University of Michigan Pancreatic Cancer Center, Immunovia partner up in fighting pancreatic cancer
University of Michigan Pancreatic Cancer Center has become the most recent member of the global network of prominent sites participating…
October 19, 2016
European Commission approves Shire’s pancreas cancer drug – ONIVYDE
European Commission (EC) has granted Marketing Authorization of ONIVYDE, also known as nal-IRI or MM-398, for the treatment of metastatic adenocarcinoma of the pancreas, in combination with 5-fluorouracil (5-FU) and leucovorin (LV), in adult patients who have progressed following gemcitabine-based therapy.